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Plain English Summary 26 
There are new ways to engage people with science and research but many patient support groups 27 
and charitable organisations still hold traditional meetings to provide updates on their activities and 28 
to report new developments in their field of interest.  These meetings often feature presentations 29 
given by medical doctors or, in the case of research-focussed organisations, by research scientists. 30 
 31 
Receiving feedback from people who are confused and sometimes upset by some types of  32 
information, and the way it is presented, at meetings made us think about better ways for 33 
researchers to discuss their ideas for new research, or share the findings from completed projects, 34 
with patients and members of the public. 35 
 36 
This article describes a method of public engagement called “Meet the Researchers” that enables 37 
people to hear about current trends in research face to face with the researchers planning or 38 
conducting it.  “Meet the Researchers” is designed to promote discussion and allow questions to be 39 
asked in a relaxed and informal way, in small groups, which is less daunting than asking questions in 40 
front of a conference audience.  The aim is to break down the barriers between researchers and 41 
patients, and enable conversations that will lead to meaningful engagement and a better 42 
understanding of research. Additionally we aim to improve understanding of how results are passed 43 
on to doctors and nurses and translated into improvements in patient care. 44 
 45 
The method was tested with patients and was rated very highly by them in the feedback they gave. 46 
 47 
 48 
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Abstract 49 
Background 50 
Innovative approaches to engaging people with science exist but are often framed around 51 
interactive events or social media technologies.  Notwithstanding the availability of novel 52 
approaches, many patient support groups and charitable organisations continue to hold traditional 53 
meetings and seminars to provide information and updates on their activities, and report on 54 
developments in their field of interest. In the case of research-focussed organisations, these 55 
meetings often take the form of presentations delivered by clinical experts or research scientists. 56 
 57 
Observation of mesothelioma patients, their relatives, friends and carers attending scientific or 58 
clinical-themed meetings has shown that they can be confused, and sometimes distressed, by 59 
presentations. This can be due to didactic presentations that are not properly targeted to this 60 
audience and a lack of a general overview or summary at the end of meetings that would provide 61 
some simple take home messages.  This experience motivated the development of a less formal 62 
method of sharing complex information and ideas, in a simplified manner.  "Meet the Researchers" 63 
aims to make researchers accessible to patients in order to raise awareness and understanding of 64 
research and to explain how research translates into, and informs practice.  This approach 65 
encourages the use of plain English, removes the tendency to rely on power point slides to convey 66 
the message and moreover, provides an opportunity for researchers to hear patients' views. 67 
 68 
Method 69 
Small groups of participants met face to face with the researchers planning or conducting research 70 
into their condition, and discussed the topics in a relaxed and informal way.  The researchers spent a 71 
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minimum of 20-minutes with each group before moving on to the next. Info-graphics or printed 72 
hand-outs in plain English were allowed but no formal presentations were made. 73 
 74 
Results 75 
Our method has been evaluated using feedback data from three annual events held from 2016 to 76 
2018:  100% of participants indicated that they liked the format "very much"(76.0%) or “quite a 77 
lot”(24.0%);  80.4% found the topics "very interesting" and 65.3% found it "very easy" to ask 78 
questions.  Free text comments revealed themes of ‘hope’ and ‘altruism’.  Researchers also reported 79 
benefits from participation such as learning about patient’ priorities and networking. 80 
 81 
Conclusion 82 
"Meet the Researchers" provides a unique opportunity for mesothelioma researchers and patients, 83 
relatives and carers to interact on a more equal footing.  It stimulates discussion, promotes 84 
understanding and provides a more informal setting for non-professional participants to ask 85 
questions. It is a format that could easily be adapted for use in other conditions. 86 
 87 
Keywords:   Patient and Public Engagement; Methods of engagement; Evaluation; Mesothelioma 88 
 89 
 90 
 91 
 92 
 93 
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Meet the Researchers: an alternative method of engaging patients with research in mesothelioma 94 
Background 95 
Mesothelioma is an asbestos-related cancer, usually but not exclusively, caused by occupational 96 
exposure.  It is classified as a rare disease, and it is recognised that patients with rare diseases can be 97 
important partners in research.[1] Mesothelioma has a long latency period and is usually diagnosed 98 
when the patient becomes symptomatic; at this stage treatment options are limited, and prognosis 99 
can be short, hence the psychological burden of the disease is high. These factors limit the 100 
willingness and the capability of patients to become actively involved in research. Building a research 101 
portfolio that reflects the needs and aspirations of mesothelioma patients can therefore be 102 
challenging. 103 
 104 
Framing the context of engagement 105 
Defining “patient engagement” is not straightforward; the literature on the topic is extensive but 106 
muddled because the terms “involvement” and “engagement” are used interchangeably.  A 107 
qualitative study and systematic review concluded that while common concepts existed, the lack of 108 
clear terminology and definitions create ambiguity and confusion among stakeholders when 109 
referring to patient engagement. REF Gallivan 2012)  For the purpose of this paper therefore we 110 
have chosen to adopt the definition of patient engagement proposed by INVOLVE: Patient 111 
engagement is where information and knowledge about research is provided and disseminated. (Ref 112 
Briefing notes for researchers http://www.invo.org.uk/posttyperesource/what-is-public-involvement-113 
in-research/) 114 
 115 
Innovative approaches to engaging people with science are often framed around technology or 116 
social media; for example the #whywedoresearch campaign.[5]  Many museums, art galleries and 117 
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other special-interest centres have interactive displays and activity centres where people can see 118 
how things work and try experiments for themselves or practice their own creative skills. 119 
Additionally, the Velindre Cancer Centre in Cardiff[6] and other NHS organisations organise 120 
laboratory visits in conjunction with charities like Cancer Research UK[7] and Cancer Research 121 
Wales[8]. Science and research roadshows are also popular and successful approaches: 122 
Southampton University’s Roadshow,[9] the CHaOS Roadshow[10] and the National Institute of 123 
Health Research “I am Research” event[11] are just three examples.  Closer to the method we 124 
describe in this paper (but not identical) is the National Cancer Research Institute’s “Meet the 125 
Expert” session,[12] which is held at their annual conference. These are informal sessions during 126 
which attendees have an opportunity to meet an eminent researcher in their field (typically a 127 
plenary speaker presenting at the Conference) and ask questions. 128 
 129 
Notwithstanding these novel approaches, many patient support groups and charitable organisations 130 
continue to hold traditional meetings and seminars to provide information and updates on their 131 
activities and report on developments in their field of interest.  In the case of research-focussed 132 
organisations, these meetings often take the form of presentations delivered by clinical experts or 133 
research scientists.  Improving methods of engagement with researchers is a first step towards 134 
developing partnership in priority setting and coproduction of research.  (See Models of 135 
engagement: Initiation REF) but evidence for the best way of achieving it is scant.(DOMECQ)   136 
 137 
In this methodological paper we describe a successful approach to patient engagement with 138 
research in mesothelioma that aims to break down the barriers between patients and researchers, 139 
and improve communication of research proposals and findings.  An evaluation of the method is also 140 
reported based on the feedback received from patients, relatives and professionals attending the 141 
last three such annual charity events. 142 
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Method 143 
From these salutary experiences the seeds of the “Meet the Researchers” concept were sown, and a 144 
fusion of speed-dating (where a group of singles meet for a fleeting date with each other, typically of 145 
3 to 4 minutes duration) and the Dragon’s Den (a popular TV series in which budding entrepreneurs 146 
present their ideas to a panel of investors) emerged.  The idea was driven by the need to move away 147 
from a traditional meeting format in which professionals ‘address’ the audience, and to create an 148 
environment more conducive to disseminating information through discourse and questions.  “Meet 149 
the Researchers” was designed to offer participants the opportunity to hear about current trends in 150 
research in small groups, face to face with the researchers planning or conducting it, and enable a 151 
discussion to flow in a relaxed and informal way.  The aim was to make researchers accessible to 152 
patients in order to raise awareness and understanding of research and to explain how research 153 
informs and translates into practice. 154 
The “Meet the Researchers” format was first enacted in a mesothelioma patient group at the June 155 
Hancock Mesothelioma Research Fund (JHMRF)[9] Action Mesothelioma Day Event in Leeds in 2011.  156 
Action Mesothelioma Day is a national event that takes place annually on the first Friday of July.  157 
Mesothelioma charities, as well as local asbestos and mesothelioma support groups, organise public 158 
meetings in different locations.  The JHMRF is a charity that relies solely on donations from the 159 
public.  It is run by volunteers and has no paid employees.  The JHMRF Action Mesothelioma Day 160 
“Meet the Researchers” event is the charity’s annual public facing event; it is free to attend.  Lunch 161 
and refreshments are provided but participants are not reimbursed for attending.  Participants 162 
include mesothelioma patients, their friends and relatives; bereaved relatives; representatives from 163 
other local cancer support groups, healthcare and legal professionals.  A breakdown of participants 164 
for the three years from 2016 to 2018 is shown in Table 1: 165 
 166 
Table 1:  Participants’ profile 2016-2018 167 
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Participant Groups* 2016 2017 2018 Total 
Patients 14 8 17 39 
Relatives/carers/ bereaved relatives 18 14 16 48 
Healthcare and other professionals 8 2 5 15 
Total providing feedback 40 24 38 102 
Percentage of total attendees 47.6% 35.8% 51.4% 45.3% 
 168 
A large room with circulation space was used and laid out in cabaret format: circular tables of 8 to 10 169 
(see Image 1).  The tables were numbered (1 to n) and two spare seats were provided at each table.  170 
Patient participants were asked not to change tables during the day.  A short introduction was given 171 
to brief participants about the research groups attending, and how the meeting would be 172 
conducted. 173 
 174 
INSERT IMAGE 1 175 
The researchers were allowed a minimum of 20-minutes at each table (timing can be flexible 176 
depending on the meeting schedule but it is important to allow time for breaks, ideally after each 177 
round of no more than three table sessions, and for summing up at the end).  Each research group (1 178 
or 2 representatives) was asked to prepare a brief introduction for a non-professional audience that 179 
could be delivered in a maximum of 5-minutes.  This was the ‘Dragon’s Den’ pitch, which outlined 180 
research interests or a specific research project; the remainder of the table session (15-minutes) was 181 
open for the ‘speed-dating’ questions from the table (see Image 2).  Aids to understanding in the 182 
form of infographics or printed handouts in plain English were permitted, and a tablet or lap-top 183 
could be used to show one or two pictures, graphs or diagrams either as part of the opening pitch or 184 
to illustrate points raised in the ensuing discussion. 185 
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INSERT IMAGE 2 186 
 187 
The research groups moved sequentially from table to table.  Group 1 started at Table 1 and 188 
progressed round the remaining tables to finish at Table 8; Group 2 started at Table 2 and moved 189 
round to finish at Table 1 and so on.  Flexibility is required in forming research groups and tables 190 
depending upon the number of attendees, and availability of researchers.  The options for group 191 
configuration are either by specific project groups or by research discipline. Table 2 shows the 192 
research groups participating in Action Mesothelioma Day 2017 as an example of the areas covered. 193 
 194 
Table 2: Research Groups 2017 195 
Group 1 Organic chemistry JHMRF PhD Fellowship: A structure-
activity study of JBIR-23 to determine the 
components required for activity against 
mesothelioma cell lines. 
Group 2 Patient Research 
Ambassador 
Patient and Public Involvement in 
research 
Group 3 Clinical research JHMRF funded project: SYSTEMS 2 A trial 
of radiotherapy for pain control in 
mesothelioma. 
Group 4 Surgical research MARS2: A feasibility study comparing 
(Extended) Pleurectomy Decortication 
versus no Pleurectomy Decortication in 
patients with mesothelioma. Funded by 
Cancer Research UK and Papworth 
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Hospital NHS Foundation Trust. 
Group 5 Thoracic Oncology Immunotherapy of MPM by blockade of 
suppressor intratumoural Treg: target 
identification 
Group 6 Cell Biology JHMRF PhD Fellowship: Understanding 
the pathogenesis of mesothelioma. 
Group 7 Applied Research RADIOMESO:  Receiving a diagnosis of 
mesothelioma: improving the patient 
experience. Funded by Mesothelioma UK 
 196 
Table moderation is the role of the facilitator assigned to each table; this is a key role (suitable for a 197 
Trustee or charity associate with the right skill set).  The facilitator assists with time keeping and 198 
eliciting or moderating the questions. They also keep notes for the summing up at the end of the 199 
event, although another person can be nominated by the table members to deliver the feedback. 200 
 201 
Three to five minutes before each table session ended, an amber warning card was shown to allow 202 
groups to wind down the discussion.  At 20-minutes an audible warning and red card signalled time 203 
to move on to the next table. It is very important to keep to time; if a discussion was unfinished or 204 
questions unanswered the table facilitator noted them so that unresolved issues could be dealt with 205 
in the breaks or during the summing up session.  The research groups are required to move on to the 206 
next table to avoid disrupting the flow and delaying the schedule.  It is also important to encourage 207 
attendees to remain with the same table group throughout the meeting to ensure they have the 208 
opportunity to meet all the research groups. 209 
 210 
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Evaluation 211 
The JHMRF has used the “Meet the Researchers” format successfully for annual Action 212 
Mesothelioma Day events from 2011 to the present. Feedback has been evaluated using two types 213 
of data: quantitative descriptive statistics derived from a standard questionnaire, and qualitative 214 
comments derived from the free text sections of the questionnaire and from email messages, texts 215 
and thank you letters sent by participants after the event. 216 
The “Meet the Researchers” format has proved to be extremely popular with people attending 217 
Action Mesothelioma Day events compared to previous events (held from 2008 to 2011), that used a 218 
traditional format featuring invited speakers and formal presentations.  We acknowledge that 219 
feedback data is generally skewed to the positive but feedback for “Meet the Researcher” events 220 
has been much improved both in terms of numbers of forms completed and number and content of 221 
comments.  Combining data from 2011 to 2018, the proportion of feedback forms completed by 222 
attendees (n = 379) was 42.0%, of which about a third were patients and more than half were 223 
relatives and carers. Less than 10.0% of participants provided feedback in the years preceding 2011. 224 
 225 
We aggregated our feedback data for the years 2016 and 2018.  Rated on a four-point categorical 226 
scale: “not at all”; “a little”; “quite a lot” and “very much”, 76.0% of respondents liked the format 227 
“very much” and 24.0% liked it “quite a lot”.  On a similar scale, 80.4% of respondents rated the 228 
topics covered as “very interesting”.  The question relating to presentation of information proved 229 
more discriminating and indicates that, although the majority of respondents found the information 230 
presented “very clear and easy to understand” (65.3%) or “quite easy” (25.3%), some still struggled: 231 
8.4% of respondents rated the information they received as “moderately easy to understand” and 232 
one respondent found it “not at all easy to understand”.  This finding supports the evidence on 233 
which the “Meet the Researchers” model is predicated: that giving information about research to 234 
patients and carers cannot be construed as a simple and straightforward undertaking.  Nevertheless, 235 
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75.9% of respondents found it “very easy” to ask the questions they wanted to ask, and this is 236 
reassuring as it suggests that the “Meet the Researchers” format does indeed facilitate interactive 237 
discussion and enables participants to ask questions more easily. 238 
 239 
Feedback from JHMRF Action Mesothelioma Day events held before 2011 focussed on practical 240 
aspects of the meeting like the venue and catering. Consequently suitable data from the events we 241 
held using a traditional format is not available to compare with our feedback from “Meet the 242 
Researchers”. 243 
 244 
Qualitative data 245 
Space was provided on the feedback forms for respondents to enter any comments about the day. 246 
While not everyone took the opportunity to express their views, a surprising number of comments 247 
were received on the forms and many verbal comments were made to, and noted by, table 248 
facilitators.  Many thank you letters, text and email messages were also received after the meetings.  249 
The comments from all years were collated and three broad categories emerged: 250 
1. Practical aspects of the meeting 251 
2. The Future 252 
3. Information 253 
 254 
1. Practical aspects of the meeting 255 
Problems experienced at the meetings, expression of thanks and appreciation, and suggestions for 256 
future events were the themes associated with the practical aspects of the meeting. Problems 257 
identified included noise from adjacent tables, difficulty hearing and fatigue. Noise, occurring as a 258 
result of many conversations taking place simultaneously, was a common complaint across all years 259 
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despite an attempt to address the problem by changing the venue for a larger room.  Increasing the 260 
distance between the tables, albeit at the expense of some exhibition space, proved to be effective.  261 
We did consider using breakout rooms but the short sessions are not conducive to moving between 262 
rooms; moreover the cost to the charity would be prohibitive, as we would need a room for each 263 
“table” of participants in addition to a large room for the collective sessions. 264 
Suggestions from participants for future events were mostly practical hints and included allowing 5-265 
minutes at the end of each table session to confer among themselves about points requiring further 266 
clarification or to formulate additional questions for the summing up session. 267 
 268 
2. The future 269 
Within The Future category were themes of hope and altruism linked with sentiments such as 270 
‘helping others’ and ‘leaving a legacy’.  Examples of comments included: 271 
 “Just being in front of a researcher gives me some hope – if not for me, for others in the future” and 272 
“It’s great to know that not everything is doom and gloom – that there is hope - that research is 273 
going on and that our input today may help researchers help mesothelioma patients even more.” 274 
 275 
3. Information 276 
Information was a broad category within which many cross-cutting themes emerged.  Many 277 
respondents described the day as “informative” or said that they “felt better informed” but were not 278 
explicit about how they had been informed; these comments were frequently linked to expressions 279 
of thanks and appreciation. A few respondents were more specific about the information they had 280 
received, for example 281 
“To be up close with the researchers was invaluable, to know what is going on behind the scenes is 282 
reassuring. Lovely, informal, informative day.” 283 
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"I found the talk on radiotherapy for the new planned treatment for pain in meso patients very 284 
informative, and the fact that it will be available at (hospital named) soon”.  285 
At our most recent event we tried to tease out why attendees felt better informed by specifically 286 
asking if attendees had found the meeting useful and to comment on this aspect.  All respondents 287 
(100% in 2018) indicated that they had found the meeting useful, and several comments were 288 
received including:  289 
“It gave information on subjects we find difficult.” 290 
“Gave a deeper understanding of research.” 291 
“Keeps me up to date with research and developments.” 292 
 293 
The professionals’ perspective 294 
We asked our researchers for feedback on the method too; some completed standard feedback 295 
forms while others preferred to send comments by email after the meeting.  We found that “Meet 296 
the Researchers” posed challenges for some researchers, especially for those who had no patient-297 
contact before or who had always used formal PowerPoint presentations in the past.  This new 298 
format of meeting gave them the opportunity to develop/practice their communication skills to a 299 
largely non-professional audience and it was perceived as a positive experience. Nearly all cancer 300 
research grant applications now request a plain English summary and the Action Mesothelioma Day 301 
meeting is an ideal forum to present ideas or results to a general audience. Meeting the sufferers of 302 
the disease can also be a humbling experience for those who are not clinical researchers.  A young 303 
laboratory scientist attending the event for the first time commented: 304 
“It was a very valuable experience for me. I've never had any form of patient contact before so there 305 
was a lot I took away from the day, and I had lots of feedback to give our team…”  306 
Another young clinical researcher commented: 307 
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“Today has be a salutary reminder of why we do research and who for….” 308 
Even more experienced researchers felt the event was worthwhile, a research group leader 309 
commented after the first event in 2011:   310 
“It was a very interesting new format as neither of us has been at a “speed dating” before! ...It 311 
worked extremely well, as people who otherwise would not have asked any questions were more 312 
confident in a small group setting to actively participate.”   313 
Another commented that it was  314 
“A worthwhile and educational experience for all”. 315 
The informal nature of the meeting also facilitates interaction and informal talks between 316 
participating scientists, working on wide-ranging aspects of mesothelioma.  317 
A full evaluation report of the feedback from Action Mesothelioma Day 2016 and 2017, including 318 
quantitative data tables and a full list of free text comments, is available on the JHMRF website.[13] 319 
 320 
Discussion 321 
The challenge of mesothelioma 322 
First-hand experience of the difficulties faced by researchers in communicating complex research 323 
ideas and results to patients with mesothelioma led us to reflect on approaches to dissemination to 324 
this patient group.  Two examples, in particular, come to mind:  first, watching patients bury their 325 
heads in their hands or become tearful when presenters show (not very optimistic) survival curves, 326 
or describe symptoms like difficult pain and breathlessness; and second, witnessing audiences in the 327 
afternoon sessions of full-day events stare, silently and glassy-eyed, at yet another presentation with 328 
numerous slides showing complicated tables and images.  The most compelling observation, 329 
however, was an encounter with a patient who left one of these meetings abruptly, saying: “I’m 330 
16 | P a g e  
 
sorry, I just have to escape – I can’t take any more of this……it’s all doom and gloom.”  This was a 331 
timely and cogent incentive to think more creatively about how we give patients information, 332 
especially those with terminal conditions. 333 
 334 
The challenge of patient engagement in mesothelioma 335 
Patient engagement in research is now an essential requirement for research grant applications to 336 
core funders like the National Institute for Health Research (NIHR)[14] and the Medical Research 337 
Council (MRC)[15].  INVOLVE was established in 1996,[16] funded by the NIHR, to support active 338 
public involvement in NHS, public health and social care research; and UK Research and Innovation 339 
(UKRI) published a recent concordat for patient engagement in 2018.[17]  As a research-funder, the 340 
JHMRF is also keen to build a research portfolio that incorporates the views, and reflects the needs, 341 
of mesothelioma patients and those close to them.  Nevertheless, involvement in research priority 342 
setting places a burden of responsibility on predominantly lay people, with varying levels of 343 
experience and preparedness for the role, at a difficult time; and it is unrealistic to expect ordinary 344 
members of the public to become consultants in research design and collaborators in the process of 345 
the research; or shapers of health care policy without helping them to acquire the knowledge and 346 
skills they need to become actively and meaningfully involved.   “Meet the Researchers” is designed 347 
to build rapport between patients and researchers thereby creating opportunities for patients to 348 
shape the JHMRF research agenda in a way that is less demanding for the patients.  By using the 349 
football analogy of red and yellow cards, and the whistle to signal time, we aimed to reduce the 350 
formality of the meeting and relax participants by adding a little fun to the event.  The short, 351 
interactive sessions diminish meeting fatigue and allow researchers and patients, relatives and 352 
carers to interact on a more equal footing. 353 
 354 
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“Meet the Researcher” (or Meet the Experts) events are held in other settings but typically these are 355 
themed around a single expert or a panel of experts, speaking with an audience.[12, 18]  The NCRI’s 356 
Dragons’ Den Workshop[19] is the closest methodological comparator as it offers the opportunity 357 
for researchers to discuss ideas with, or pitch research projects, to small panels of patients, 358 
corresponding to our table sessions at our “Meet the Researchers” event.  The major difference is 359 
that the NCRI Dragons’ Den is focussed on partnership, problem-solving and co-production in 360 
relation to research proposals.  “Meet the Researchers” is not designed to appraise research but 361 
aims to raise patients’ awareness of research in mesothelioma and help them to understand the way 362 
research is funded, conducted, reported and eventually translated into practice.  An unanticipated 363 
outcome from our qualitative evaluation of the method was the extent to which researchers 364 
reported learning from the event.  This supports the argument postulated by Staley (2017) that we 365 
should rethink our definition of impact when evaluating patient engagement and involvement 366 
activities.(STALEY 2). 367 
 368 
The “Meet the Researchers” method of engagement is not limited exclusively to research.  For 369 
example, if the meeting focus is on care, “Meet the Experts” could be conducted in a similar way 370 
with medical specialists, specialist nurses, allied healthcare professionals from different disciplines or 371 
medico-legal experts forming the expert groups. In this example, however, it is important for the 372 
table facilitator to moderate the table conversations effectively, and prevent individual cases 373 
becoming predominant.  This was a problem we encountered when we mixed research and clinical 374 
experts for our “Meet the Experts” event in 2015. 375 
 376 
Although we have not used our method for more targeted patient involvement activities, we 377 
speculate that it could also be applied to identify patients’ priorities for research, or elicit patients’ 378 
views on study design when planning a new project.  A 2014 review by Brett et al reported that lack 379 
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of preparation and training led some service users to feel unable to contribute to the research, while 380 
other service users and communities reported feeling overburdened with the work involved. 381 
Researchers reported difficulties in incorporating PPI in meaningful ways due to lack of money and 382 
time.[21]  “Meet the Researchers could potentially overcome some of these difficulties by linking 383 
researchers with a large number of patients, without the time or expense of separate meetings or by 384 
replacing reviews of lengthy, written research proposals with group discussions, thereby reducing 385 
the workload for patients. 386 
 387 
Limitations of the method and evaluation 388 
There are some aspects of our methods that require refinement; for example providing additional 389 
breaks during the sessions to reduce fatigue (both patients and experts) and managing the noise 390 
level, which we overcame in 2018 by increasing the distance between the tables albeit at the 391 
expense of exhibition space for our charity and our partners in the event.  Feedback from all 392 
participants also suggested that better briefing of researchers and table facilitators is required to 393 
ensure that information is presented, and questions are answered, in a clear and accessible way.  394 
Moreover, a brief outline of researchers and their field of expertise would be valued by both 395 
professional and non-professional participants to enable table facilitators and attendees to prepare 396 
questions, and researchers to cross-reference each other’s work to link up discussions more 397 
effectively and not appear as isolated, unconnected examples coming from individual laboratories.  398 
This latter suggestion was implemented at our most recent (2018) event and was well received; 399 
evidenced by the fact that not a single programme was left behind at the end of the meeting. 400 
 401 
We acknowledge that our evaluation is constrained by the nature of the data collected from 402 
feedback forms.  We also recognise that assessing the impact and benefit of engagement activities 403 
for patients is difficult because methods of evaluation are under-developed and evidence is 404 
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limited.(STALEY 1)  Reports of similar events are generally found only in organisations’ newsletters 405 
and on their websites.  A scoping review revealed only one published paper reporting an evaluation 406 
of event feedback.[20]  This event (a national PPI day for thyroid eye disease) used a combination of 407 
approaches to engagement, including didactic lectures, and focus group discussions.  It received 408 
excellent feedback: 52% of attendees at the event provided feedback and of these respondents, 88% 409 
rated it very good or excellent.  This is comparable with the feedback we received at our “Meet the 410 
Researchers” event but it is not possible to comment on whether the combination of lectures and 411 
focus groups is better than our informal discussion-based approach due to the limitations of 412 
feedback data.  Options for wider comparison of our results are limited because reviews of patient 413 
engagement activities tend to focus on the impact, not the method, of engagement on research or 414 
practice. 415 
 416 
Conclusion 417 
"Meet the Researchers" is a method of public engagement that provides a unique opportunity for 418 
mesothelioma researchers and patients, relatives and carers to hear about current trends in 419 
research face to face with the researchers planning or conducting it.  The informal approach breaks 420 
down the barriers between researchers and patients and enables interaction on a more equal 421 
footing, without the use of PowerPoint presentations.  This reduces the impression that researchers 422 
are “talking to” the participants and helps stimulate conversations that lead to meaningful 423 
engagement, and a better understanding of research.(PPT REF) 424 
 425 
Feedback from our Action Mesothelioma Days has shown that participants felt empowered to ask 426 
questions because they found it less daunting to speak in small groups than they would in front of a 427 
conference audience.  They also reported feeling better informed after the event and, importantly, 428 
said they felt that their experiences and opinions were valued.  This is an encouraging outcome 429 
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because being better informed and feeling able to contribute are springboards to future 430 
involvement.  Moreover, the participating researchers said they had benefitted and this too has 431 
important implications for facilitating future research collaborations and co-production. 432 
 433 
The practical details included in the paper will be useful to the organisers of patient engagement 434 
events, particularly those seeking a new approach.  The evaluation of the feedback provides some 435 
insight into the application of the method and how is received by participants.  The "Meet the 436 
Researchers" method could easily be replicated or adapted for use in other conditions and settings. 437 
It is also flexible and can focus on one theme or cover a range of topics from basic science to clinical 438 
trials and health services research.  In this way, patients can be supported to recognise the different 439 
types and stages of research, and understand how results are passed on to doctors and nurses and 440 
translated into improvements in patient care. 441 
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